183 research outputs found
El rol del Ministerio Público en los procesos de protección contra las violencias
Este trabajo busca analizar el rol del Asesor de Menores e Incapaces en las decisiones y prácticas judiciales de los procesos que implique la investigación, cese y reparación al maltrato infantil que sufren directa e indirectamente los niños, niñas y adolescentes. Dicho objetivo se realiza mediante el cotejo de dos casos ocurridos en la Provincia de Buenos Aires donde este asume la función de promotor y contralor encontrándose latente la aplicación de la figura procesal del “desistimiento” en un proceso especial donde pueden existir intereses contrapuestos entre los/as niños/as y adolescentes, y uno o ambos progenitores quienes además de autores pueden ser víctimas de violencia.
Machine learning-based ability to classify psychosis and early stages of disease through parenting and attachment-related variables is associated with social cognition
Background: Recent views posited that negative parenting and attachment insecurity can be considered as general
environmental factors of vulnerability for psychosis, specifically for individuals diagnosed with psychosis (PSY).
Furthermore, evidence highlighted a tight relationship between attachment style and social cognition abilities, a key
PSY behavioral phenotype. The aim of this study is to generate a machine learning algorithm based on the perceived
quality of parenting and attachment style-related features to discriminate between PSY and healthy controls (HC)
and to investigate its ability to track PSY early stages and risk conditions, as well as its association with social cognition
performance.
Methods: Perceived maternal and paternal parenting, as well as attachment anxiety and avoidance scores, were
trained to separate 71 HC from 34 PSY (20 individuals diagnosed with schizophrenia + 14 diagnosed with bipolar
disorder with psychotic manifestations) using support vector classification and repeated nested cross-validation. We
then validated this model on independent datasets including individuals at the early stages of disease (ESD, i.e. first
episode of psychosis or depression, or at-risk mental state for psychosis) and with familial high risk for PSY (FHR, i.e.
having a first-degree relative suffering from psychosis). Then, we performed factorial analyses to test the group x classification
rate interaction on emotion perception, social inference and managing of emotions abilities.
Results: The perceived parenting and attachment-based machine learning model discriminated PSY from HC with a
Balanced Accuracy (BAC) of 72.2%. Slightly lower classification performance was measured in the ESD sample (HC-ESD
BAC = 63.5%), while the model could not discriminate between FHR and HC (BAC = 44.2%). We observed a significant
group x classification interaction in PSY and HC from the discovery sample on emotion perception and on the ability
to manage emotions (both p = 0.02). The interaction on managing of emotion abilities was replicated in the ESD and
HC validation sample (p = 0.03).
Conclusion: Our results suggest that parenting and attachment-related variables bear significant classification
power when applied to both PSY and its early stages and are associated with variability in emotion processing. These variables could therefore be useful in psychosis early recognition programs aimed at softening the psychosis-associated
disability
Histological hallmarks of mucosal healing in inflammatory bowel diseases in the era of monoclonal antibodies therapy: New insights and perspectives
Background: Chronic inflammatory bowel diseases (IBDs) are gaining increasing attention, both because they can severely reduce the quantity and quality of life, and because the advent of monoclonal antibodies has profoundly changed the natural history of these diseases. In recent years, the concept of mucosal healing has assumed a certain importance, and there are more and more clinical and pharmacological trials that consider this parameter among their endpoints, so much so that it may soon be included among the desirable clinical outcomes of patients with IBD. Methods: We performed a literature review of the Pubmed, Medline, and Web of Science (WoS) databases. Results: We selected 88 articles and then removed 6 duplicates; the final sample after accurate application of the inclusion criteria numbered 73 articles, with a level of evidence rating of three or four, according to Oxfords Evidence-based medicine. Our aim was to study the histological impact of monoclonal antibody therapies on mucosal healing, taking into consideration the few studies present in the literature. To perform this review, we compared studies that examined patients with Crohn’s disease (CD) and/or ulcerative colitis (UC) undergoing monoclonal therapy versus patients undergoing other non-biological therapies (PICO statements). Conclusions: We try to delineate how monoclonal antibodies have changed the natural history of IBD, acting at the microscopic level, and we believe that a careful analysis of the histopathology and the definition of the objective criteria for “Mucosa Healing” should enable this concept to be included among the clinical endpoints of patients affected by IBD, thus contributing to a better therapeutic management of these patients
Avaliação da qualidade educacional da Faculdade de Educação (FACED) da Universidade Federal do Ceará (UFC)
Evidence of an interaction between FXR1 and GSK3 beta polymorphisms on levels of Negative Symptoms of Schizophrenia and their response to antipsychotics
Background:
Genome-Wide Association Studies (GWASs) have identified several genes associated with Schizophrenia (SCZ) and exponentially increased knowledge on the genetic basis of the disease. In addition, products of GWAS genes interact with neuronal factors coded by genes lacking association, such that this interaction may confer risk for specific phenotypes of this brain disorder. In this regard, fragile X mental retardation syndrome-related 1 (FXR1) gene has been GWAS associated with SCZ. FXR1 protein is regulated by glycogen synthase kinase-3β (GSK3β), which has been implicated in pathophysiology of SCZ and response to antipsychotics (APs). rs496250 and rs12630592, two eQTLs (Expression Quantitative Trait Loci) of FXR1 and GSK3β, respectively, interact on emotion stability and amygdala/prefrontal cortex activity during emotion processing. These two phenotypes are associated with Negative Symptoms (NSs) of SCZ suggesting that the interaction between these SNPs may also affect NS severity and responsiveness to medication.
Methods:
To test this hypothesis, in two independent samples of patients with SCZ, we investigated rs496250 by rs12630592 interaction on NS severity and response to APs. We also tested a putative link between APs administration and FXR1 expression, as already reported for GSK3β expression.
Results:
We found that rs496250 and rs12630592 interact on NS severity. We also found evidence suggesting interaction of these polymorphisms also on response to APs. This interaction was not present when looking at positive and general psychopathology scores. Furthermore, chronic olanzapine administration led to a reduction of FXR1 expression in mouse frontal cortex.
Discussion:
Our findings suggest that, like GSK3β, FXR1 is affected by APs while shedding new light on the role of the FXR1/GSK3β pathway for NSs of SCZ
PROGRAMA INSTITUCIONAL DE BOLSA DE INICIAÇÃO À DOCÊNCIA (PIBID): DESEMPENHO DE BOLSISTAS VERSUS NÃO BOLSISTAS
The Brief Negative Symptom Scale (BNSS): Independent validation in a large sample of Italian patients with schizophrenia
BACKGROUND:
The Brief Negative Symptom Scale (BNSS) was developed to address the main limitations of the existing scales for the assessment of negative symptoms of schizophrenia. The initial validation of the scale by the group involved in its development demonstrated good convergent and discriminant validity, and a factor structure confirming the two domains of negative symptoms (reduced emotional/verbal expression and anhedonia/asociality/avolition). However, only relatively small samples of patients with schizophrenia were investigated. Further independent validation in large clinical samples might be instrumental to the broad diffusion of the scale in clinical research.
METHODS:
The present study aimed to examine the BNSS inter-rater reliability, convergent/discriminant validity and factor structure in a large Italian sample of outpatients with schizophrenia.
RESULTS:
Our results confirmed the excellent inter-rater reliability of the BNSS (the intraclass correlation coefficient ranged from 0.81 to 0.98 for individual items and was 0.98 for the total score). The convergent validity measures had r values from 0.62 to 0.77, while the divergent validity measures had r values from 0.20 to 0.28 in the main sample (n=912) and in a subsample without clinically significant levels of depression and extrapyramidal symptoms (n=496). The BNSS factor structure was supported in both groups.
CONCLUSIONS:
The study confirms that the BNSS is a promising measure for quantifying negative symptoms of schizophrenia in large multicenter clinical studies
Does social cognition change? Evidence after 4 years from the Italian Network for Research on Psychoses
BackgroundDeficits in social cognition (SC) are significantly related to community functioning in schizophrenia (SZ). Few studies investigated longitudinal changes in SC and its impact on recovery. In the present study, we aimed: (a) to estimate the magnitude and clinical significance of SC change in outpatients with stable SZ who were assessed at baseline and after 4 years, (b) to identify predictors of reliable and clinically significant change (RCSC), and (c) to determine whether changes in SC over 4 years predicted patient recovery at follow-up. MethodsThe reliable change index was used to estimate the proportion of true change in SC, not attributable to measurement error. Stepwise multiple logistic regression models were used to identify the predictors of RCSC in a SC domain (The Awareness of Social Inference Test [TASIT]) and the effect of change in TASIT on recovery at follow-up. ResultsIn 548 participants, statistically significant improvements were found for the simple and paradoxical sarcasm of TASIT scale, and for the total score of section 2. The reliable change index was 9.8. A cut-off of 45 identified patients showing clinically significant change. Reliable change was achieved by 12.6% and RCSC by 8% of participants. Lower baseline TASIT sect. 2 score predicted reliable improvement on TASIT sect. 2. Improvement in TASIT sect. 2 scores predicted functional recovery, with a 10-point change predicting 40% increase in the probability of recovery. ConclusionsThe RCSC index provides a conservative way to assess the improvement in the ability to grasp sarcasm in SZ, and is associated with recovery
- …